FDA Approved: LEVETIRACETAM — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves Cranbury Pharmaceuticals' original application for a generic levetiracetam, supporting its use for partial-onset seizures, myoclonic seizures in ju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Generalized Epilepsy
• Juvenile Myoclonic Epilepsy
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)